In summary, data showing that anti-DEspR antibody treatment can decrease tumor-seeding and feed-forward dissemination-progression, resulting in significantly increased mOS in both male and female rats with xenografted PPC, collectively suggest a novel therapeutic paradigm for PPC. This evidence concerns the gene FBXW7-AS1 and neoplasm.